Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
rett syndrome
MeSH D015518 - rett syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D038901:
X-linked mental retardation
0 Companies
0 Drugs
Success rate
D015518:
Rett syndrome
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Acadia Pharmaceuticals
Trofinetide
Daybue
2032-01-27
2023-03-10
Clinical Trials
Historical Success Rate
Phase 1
100
%
4/4
Phase 2
30
%
6/20
Phase 3
0
%
0/9
Approved:
0
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Acadia Pharmaceuticals
Trofinetide
,
Lavender
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use